Trial Profile
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and pioglitazone in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Mar 2011
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 14 Mar 2011 New trial record